Half Year Report on Adocia’s Liquidity Agreement with Kepler Capital Markets
Regulatory News:
Under the liquidity agreement entrusted by Adocia (Paris:ADOC) to Kepler Capital Markets, the following resources were
listed on the liquidity account as at June 30, 2016:
- 3,575 shares of Adocia and
- 149,679.76 euros in cash.
At the last half year report dated December 31, 2015:
- 4,185 shares of Adocia and
- 132,740.22 euros in cash.
About ADOCIA
Adocia is a clinical-stage biotechnology company that specializes in the development of innovative formulations of
already-approved therapeutic proteins. Adocia’s insulin formulation portfolio, featuring four clinical-stage products and one
preclinical product, is among the largest and most differentiated in the industry.
The proprietary BioChaperone® technological platform is designed to enhance the effectiveness and/or safety of
therapeutic proteins while making them easier for patients to use. Adocia customizes BioChaperone to each protein for a given
application in order to address specific patient needs.
Adocia’s clinical pipeline includes a unique formulation of PDGF-BB for the treatment of diabetic foot ulcer and four novel
insulin formulations for the treatment of diabetes: two ultra-rapid formulations of insulin analogs (BioChaperone Lispro U100 and
U200), a rapid-acting formulation of human insulin (HinsBet U100) and a combination of insulin glargine and a rapid-acting insulin
analog (BioChaperone Combo). Adocia is also developing a concentrated, rapid-acting formulation of human insulin (HinsBet
U500).
In December 2014, Adocia signed a partnership with Eli Lilly for the development and commercialization of the BioChaperone
Lispro projects.
Adocia aims to deliver “Innovative medicine for everyone, everywhere.”
To learn more about Adocia, please visit us at www.adocia.com
Adocia
Gérard Soula, Tél. : +33 4 72 610 610
Chairman and CEO
contactinvestisseurs@adocia.com
or
Adocia Press Relations Europe
MC Services AG
Raimund Gabriel, Tél. : +49 89 210 228 0
raimund.gabriel@mc-services.eu
adocia@mc-services.eu
or
Adocia Investor Relations USA
The Ruth Group
Tram Bui, Tel. : +646.536.7035
tbui@theruthgroup.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20160705005750/en/